Clemens Schotten

993 total citations
6 papers, 188 citations indexed

About

Clemens Schotten is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Clemens Schotten has authored 6 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 3 papers in Epidemiology and 1 paper in Surgery. Recurrent topics in Clemens Schotten's work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Disease and Transplantation (2 papers). Clemens Schotten is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Liver Disease Diagnosis and Treatment (3 papers) and Liver Disease and Transplantation (2 papers). Clemens Schotten collaborates with scholars based in Germany, United Kingdom and Egypt. Clemens Schotten's co-authors include Jan Best, Alexander Dechêne, Paul Manka, Dominik Heider, Judith Ertle, Sotiria Bedreli, Leo A. van Grunsven, Guido Gerken, Heiner Wedemeyer and Christian M. Lange and has published in prestigious journals such as Pharmaceuticals, Expert Opinion on Pharmacotherapy and Liver Cancer.

In The Last Decade

Clemens Schotten

6 papers receiving 180 citations

Peers

Clemens Schotten
Clemens Schotten
Citations per year, relative to Clemens Schotten Clemens Schotten (= 1×) peers M.L. González-Diéguez

Countries citing papers authored by Clemens Schotten

Since Specialization
Citations

This map shows the geographic impact of Clemens Schotten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clemens Schotten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clemens Schotten more than expected).

Fields of papers citing papers by Clemens Schotten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clemens Schotten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clemens Schotten. The network helps show where Clemens Schotten may publish in the future.

Co-authorship network of co-authors of Clemens Schotten

This figure shows the co-authorship network connecting the top 25 collaborators of Clemens Schotten. A scholar is included among the top collaborators of Clemens Schotten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clemens Schotten. Clemens Schotten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Benkö, Tamás, Julia König, Jens Theysohn, et al.. (2022). Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?. European journal of medical research. 27(1). 74–74. 11 indexed citations
2.
Schotten, Clemens, Jan‐Peter Sowa, Paul Manka, et al.. (2021). GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients. Pharmaceuticals. 14(8). 735–735. 34 indexed citations
3.
Haubold, Johannes, Axel Wetter, Yan Li, et al.. (2020). DSM-TACE of HCC: Evaluation of Tumor Response in Patients Ineligible for Other Systemic or Loco-Regional Therapies. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 192(9). 862–869. 12 indexed citations
4.
Schotten, Clemens, Lars P. Bechmann, Paul Manka, et al.. (2019). NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization. Liver Cancer. 8(6). 491–504. 17 indexed citations
5.
Best, Jan, et al.. (2017). Tivantinib for the treatment of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy. 18(7). 727–733. 24 indexed citations
6.
Best, Jan, Dominik Heider, Clemens Schotten, et al.. (2016). The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma. Zeitschrift für Gastroenterologie. 54(12). 1296–1305. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026